Small Molecule Inhibitors of MDM2-p53 and MDMX-p53 Interactions as New Cancer Therapeutics
Inactivation of the function of tumor suppressor p53 is common in human cancers. In approximately half of human cancers, the tumor suppressor function of p53 is inactivated by deletion or mutation of TP53, the gene encoding p53 protein. In the remaining 50% of human cancers, p53 tumor suppressor fun...
Main Authors: | Yujun Zhao, Denzil Bernard, Shaomeng Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2013-07-01
|
Series: | BioDiscovery |
Subjects: | |
Online Access: | https://biodiscovery.pensoft.net/article/8950/download/pdf/ |
Similar Items
-
Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
by: Zuzana Mrkvová, et al.
Published: (2019-06-01) -
Controlling the Mdm2-Mdmx-p53 Circuit
by: David L. Waning, et al.
Published: (2010-05-01) -
MDMX is essential for the regulation of p53 protein levels in the absence of a functional MDM2 C-terminal tail
by: Jack D. Sanford, et al.
Published: (2021-09-01) -
Synthesis and Biological Evaluation of Novel Synthetic Indolone Derivatives as Anti-Tumor Agents Targeting p53-MDM2 and p53-MDMX
by: Yali Wang, et al.
Published: (2022-06-01) -
Role of the N-terminal lid in regulating the interaction of phosphorylated MDMX with p53
by: Chan, Jane Vin, et al.
Published: (2018)